Yahoo Web Search

  1. The FDA was fairly active this week, granting approval for expanded use of Merck’s MRK blockbuster PD-L1 inhibitor, Keytruda and J&J’s JNJ new prostate cancer drug, Erleada. The regulatory ...

  2. An experimental Amgen Inc drug that targets a specific genetic mutation reduced tumor size in around half of advanced lung cancer patients given the highest dose in a small, early-stage ...

  3. The FDA accepts Seattle Genetics (SGEN) and Astellas' BLA for enfortumab vedotin under a priority review to treat advanced/metastatic urothelial cancer. A verdict is pending on Mar 15, 2020.

  4. Breast Cancer Drugs May Inflame Lungs Per FDA Safety Alert

    Zacks via Yahoo FinanceSep 16 12:33 PM

    The FDA approves new warnings about inflammation risk to be added to labels of Pfizer's (PFE) Ibrance, Eli Lilly's (LLY) Verzenio and Novartis' (NVS) Kisqali.

  5. Edited Transcript of IMV.TO earnings conference call or presentation 9-Aug-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceSep 02 15:40 PM

    Looking ahead, I'm pleased to confirm that we have now enrolled 16 additional patients of the expanded monotherapy arm, and that time, we expect to provide a top line clinical results from this ...

  6. NASDAQ: BASI) China Biologic Products Holdings Inc (NASDAQ: CBPO) (announced a go-private offer) Cesca Therapeutics Inc (NASDAQ: KOOL) Enlivex Therapeutics Ltd (NASDAQ: ENLV) Medpace ...

  7. Major stock indexes fell into negative territory after the cancellation, which came as trade talks were held in Washington and U.S. President Donald Trump said he wanted a complete trade deal ...

  8. Eli Lilly and Co's Trulicity, an injectable rival, has a list price of $759.40 per month, according to Lilly's website.

  9. US STOCKS-Wall Street drops as trade tensions spike

    Reuters via Yahoo FinanceSep 20 18:14 PM

    The Wall Street's main indexes dropped on Friday, after the Montana Farm Bureau said Chinese agriculture officials who were due to visit U.S. farm states next week canceled their trip, dampening ...

  10. Edited Transcript of OPGN earnings conference call or presentation 7-Aug-19 8:30pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceSep 13 23:48 PM

    Assuming we successfully work to this time line and the FDA supports our responses, we would anticipate receiving clearance for the Acuitas AMR Gene Panel for use with bacterial isolates in ...

  1. Ad
    related to MERCK & CO., INC